Fycompa
Sponsors
PNA Center for Neurological Research, Eisai Co., Ltd., Eisai Inc., American University of Beirut Medical Center, University of Florida
Conditions
Amyotrophic Lateral SclerosisCatamenial EpilepsyEpilepsyNeuropathy, Small FiberPartial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Phase 2
Phase 4
Unknown Phase
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
CompletedNCT03059381
Start: 2016-08-01End: 2021-03-21Updated: 2022-08-05
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
CompletedNCT03059329
Start: 2016-08-01End: 2019-09-13Updated: 2022-03-02
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
CompletedNCT03208660
Start: 2017-04-07End: 2019-03-15Updated: 2019-04-11